Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec 1;33(1S Suppl 1):e1090.
doi: 10.1097/MEG.0000000000002192.

Mind the lipids: hyperlipidaemia resultant from JAK inhibitor use in inflammatory bowel disease

Alexander Ng  1
Affiliations
Comment

Mind the lipids: hyperlipidaemia resultant from JAK inhibitor use in inflammatory bowel disease

Alexander Ng. Eur J Gastroenterol Hepatol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Magrì S, Chessa L, Demurtas M, Cabras F, Mocci G. Review article: safety of new biologic agents for inflammatory bowel disease in the liver. Eur J Gastroenterol Hepatol 2021; 33:623–630.
    1. Honap S, Chee D, Chapman TP, Patel M, Kent AJ, Ray S, et al.; LEO [London, Exeter, Oxford] IBD Research Consortium. Real-world effectiveness of tofacitinib for moderate to severe ulcerative colitis: a multicentre UK experience. J Crohns Colitis 2020; 14:1385–1393.
    1. Sandborn WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, Van Assche G, D'Haens G, et al. Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s Disease. Gastroenterol 2020; 158:2123–2138.e8.
    1. Arguello G, Balboa E, Arrese M, Zanlungo S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim Biophys Acta 2015; 1852:1765–1778.
    1. Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, et al. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme. RMD Open 2020; 6:e001395.

LinkOut - more resources